The drug, made from a combination of two antibodies, failed its main goal to treat Covid-19 symptoms in exposed patients, AstraZeneca said ...

The advice for healthcare professionals was provided by the European Medicines Agency (EMA) as part of an ongoing review into rare, but sev...

The EU's executive branch has launched legal proceedings in Belgium against the firm for what it believes amounts to a breach of contract a...

Sarah Walters, AstraZeneca's Austria country manager, told the Kurier newspaper that studies, so far, indicating the existing AstraZeneca v...

Last week, South Korea suspended the use of AstraZeneca vaccines for those 60 years old or younger while awaiting the outcome of the Europe...

The decision was announced soon after the European Union's drug regulator said it had found a ``possible link'' between the AstraZeneca cor...

There is a causal link between the coronavirus vaccine developed by AstraZeneca and very rare cases of blood clots, although it remains unc...

The decision came after the country's medical regulator announced that it had received a total of 31 reports of rare blood clots in recent ...

In a communique to Union Health Secretary Rajesh Bhushan on Tuesday, the Director of Government and Regulatory Affairs at the Pune-based Se...

As things stand, it's either AstraZeneca or nothing for some poorer countries. The vaccine from the Anglo-Swedish drug maker is cheaper and...

The World Health Organization, AstraZeneca, and the European Medicines Agency have insisted the shot is safe, and that there is no link bet...

AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vac...

The WHO said on Monday that it was clearing the AstraZeneca vaccines made by the Serum Institute of India and South Korea's AstraZeneca-SKB...

The two sets of experts are to join forces to explore if a combination of the two jabs, both using a benign virus called adenovirus, could ...

Bangladesh health minister Zahid Maleque said 5 million doses of vaccine per month would be purchased through Bangladesh's drug maker, Bexi...

The study had been previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it ...

Last month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical t...